Research has shown that people living with early-stage breast cancer who test positive for circulating tumor DNA (ctDNA) in their blood are at a higher risk for breast cancer recurrence.
People with obesity or who are overweight are also at an increased risk for breast cancer recurrence.
People who meet the following criteria may be eligible. These are the key requirements. There may be additional criteria the study team uses to determine eligibility.
If you are interested in participating in the TRIM-EBC clinical trial, here is what you can expect:
Step 1
Talk to the study team about your eligibility for clinical trial
Step 2
Provide a blood sample for ctDNA evaluation
Step 3
If ctDNA is not found, retest every 3 months for up to 3 years
Step 4
If ctDNA is found, you will have an imaging evaluation to check for metastasis
Step 5
Receive a weekly Zepbound injection while on the trial
Step 6
Periodic visits with the study team to monitor for weight loss, side effects, and ctDNA
Participating in a clinical trial is a big decision. We want to make sure you have the answers you need to make the choice that’s right for you.
